NCT02330081View on ClinicalTrials.gov

Survival and Recovery of Radio-labeled Platelets Derived From Mirasol-treated Whole Blood

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Blood Safety
Interventions
DEVICE

Mirasol treatment of whole blood

"Subject will be infused with two products at the same time:~1. radio-labeled platelets derived from subject's stored whole blood which has been treated with Mirasol.~2. radio-labeled platelets derived from subject's untreated fresh whole blood."

Trial Locations (1)

2021

Haukeland University Hospital, Bergen

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Terumo BCTbio

INDUSTRY

NCT02330081 - Survival and Recovery of Radio-labeled Platelets Derived From Mirasol-treated Whole Blood | Biotech Hunter | Biotech Hunter